| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 440,924 | 415,472 | 226,683 | 438,817 | | Cost of Revenue | 383,054 | 369,025 | 218,526 | 398,754 | | | Gross Profit | 57,870 | 46,447 | 8,157 | 40,063 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 25,942 | 33,971 | 30,199 | 34,466 | | Non Recurring |
-
| 7,864 | 2,044 |
-
| | Others | 476 |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 31,452 | 4,612 | (24,086) | 5,597 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,211 | 104 | 1,247 | 2,783 | | Earnings Before Interest And Taxes | 33,663 | 4,716 | (22,839) | 8,380 | | Interest Expense | 139 | 144 | 112 | 130 | | Income Before Tax | 33,524 | 4,572 | (22,951) | 8,250 | | Income Tax Expense | 8,743 | 2,470 | (8,091) | 3,130 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 24,781 | 2,102 | (14,860) | 5,120 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 24,781 | 2,102 | (14,860) | 5,120 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $24,781 | $2,102 | ($14,860) | $5,120 |
|
0.29% Nasdaq 
Income Statement
